
Reset all filters
01 6Zenara Pharma
02 1Accord healthcare
03 6Ajanta Pharma Limited
04 6Alembic Pharmaceuticals Limited
05 6Alkem Laboratories
06 6Amneal Pharmaceuticals
07 5Apotex Inc
08 6Aurobindo Pharma Limited
09 6Chartwell Pharmaceuticals llc
10 14H. Lundbeck AS
11 6Hetero Drugs
12 6Intas Pharmaceuticals
13 6Lupin Ltd
14 6MSN Laboratories
15 6Otsuka Chemical Co Ltd
16 6Otsuka Holdings
17 11Otsuka Pharmaceutical
18 6Prinston
19 6Sandoz B2B
20 6Teva Pharmaceutical Industries
21 6Zydus Pharmaceuticals
Reset all filters
01 16Film Coated Tablet
02 5TAB
03 6TABLET
04 1TABLET; ORAL
05 95TABLET;ORAL
06 6Tablet
07 4Blank
Reset all filters
01 5Allowed
02 6Approved
03 5Authorized
04 65DISCN
05 5Originator
06 6Prescription
07 12RX
08 29Blank
Reset all filters
01 90BREXPIPRAZOLE
02 12REXULTI
03 14Rexulti
04 11Rxulti
05 6Blank
Reset all filters
01 4Australia
02 6Canada
03 6India
04 5South Africa
05 5Spain
06 6Sweden
07 5Switzerland
08 96USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA